Dermatology

HomeAbout UsFacultyKristina Callis Duffin, M.D.

Kristina Callis Duffin, M.D.

Kristina Callis Duffin, M.D.

Assistant Professor in Dermatology

  • B.S., Summa Cum Laude, 1989, Montana State University
  • M.D., Cum Laude, AOA, 1993, University of Washington School of Medicine
  • Residency in Internal Medicine, 1994-1997, Maine Medical Center
  • Clinical Research Fellowship in Dermatology, 2000-2002, University of Utah
  • Residency in Dermatology, 2002-2005, University of Utah
  • Board Certification in Internal Medicine and Dermatology

Clinical and Research Interests

  • Dr. Duffin's principal clinical interests are General Dermatology and Psoriasis. Her research interests include Psoriasis: Clinical Trials and the Genetics of Psoriasis.
  • She is the Co-director of the Utah Psoriasis Initiative.

Selected Publications

  • Callis Duffin K, Freeny I, Schrodi SJ, Wong B, Feng B, Soltani-Arabshahi R, Rakkhit T, Goldgar DE, and Krueger GG. Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking. J Invest Dermatol. 2009, Jun (epub ahead of print)
  • Callis Duffin K, Wong B, Horn EJ, Krueger GG. Psoriatic arthritis is a strong predictor of sleep interference in patients with psoriasis. J Am Acad Dermatol, 2009; 60(4), 604-8.
  • Rakkhit T, Panko JM, Christensen TE, Wong B, Nelson T, Papenfuss J, Hansen CB, Callis Duffin K, Krueger GG. Plaque thickness and morphology in psoriasis vulgaris associated with therapeutic response. Br J Dermatol, 2009; 160(5), 1083-9.
  • Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, Gudjonsson JE, Li Y, Tejasvi T, Feng BJ, Ruether A, Schreiber S, Weichenthal M, Gladman D, Rahman P, Schrodi SJ, Prahalad S, Guthery SL, Fischer J, Liao W, Kwok PY, Menter A, Lathrop GM, Wise CA, Begovich AB, Voorhees JJ, Elder JT, Krueger GG, Bowcock AM, Abecasis GR. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet, 2009; 41(2), 199-204.
  • Chandra V, Gottlieb A, Cook RJ, Callis Duffin K, Garg A, Helliwell P, Kavanaugh A, Krueger GG, Langley R, Lynde C, McHugh N, Mease P, Olivieri I, Rahman P, Rosen CF, Salvarani C, Thaci D, Toloza SMA, Wong M, Zhou Q, Gladman DD. International Multi-centre Psoriasis and Psoriatic Arthritis Reliability Trial (GRAPPA-IMPART): Assessment of Skin, Joints, Nails, and Dactylitis. Arthritis Care Res. 2009 (Accepted for Publication)
  • Duffin KC, Chandran V, Gladman DD, Krueger GG, Elder JT, Rahman P. Genetics of psoriasis and psoriatic arthritis: update and future direction. J Rheumatol, 2008; 35(7), 1449-53.
  • Duffin KC, Krueger GG. Genetic variations in cytokines and cytokine receptors associated with psoriasis found by genome-wide association. J Invest Dermatol, 2009; 129(4), 827-33.
  • Callis Duffin, KP, Krueger GG. Topical Agents in the Treatment of Moderate-to-Severe Psoriasis. In John YM Koo, Chai Sue Lee, Mark G. Lebwohl, Gerald D. Weinstein, and Alice Gottlieb (Eds.), Moderate-to-Severe Psoriasis (third, 1, pp.59-74). New York: Informa Healthcare USA, Inc. 2009.
  • Grande Sarpa H, Harris R, Hansen CD, Callis Duffin KP, Florell SR, Hadley ML. Androgen receptor expression patterns in Becker's nevi: an immunohistochemical study. J Am Acad Dermatol, 2008; 59(5), 834-8.
  • Qureshi AA, Dominguez P, Duffin KC, Gladman DD, Helliwell P, Mease PJ, Husni ME. Psoriatic arthritis screening tools. J Rheumatol, 2008; 35(7), 1423-5.
  • Garcia, VE, Chang M, Brandon R, Li Y, Matsunami N, Callis Duffin KP, Civello D, Rowland CM, Bui N, Catanese JJ, Kreuger GG, Leppert MF, Begovich AB, Schrodi SJ. Detailed genetic characterization of the interleukin-23 receptor in psoriasis. Genes Immun, Sep 2008; 9(6), 546-55.
  • Li Y, Liao W, Chang M, Schrodi SJ, Bui N, Catanese JJ, Poon A, Matsunami N, Duffin KC, Leppert MF, Bowcock AM, Kwok PY, Krueger GG, Begovich AB. Further genetic evidence for three psoriasis risk genes: ADAM33, CDKAL1 and PTPN22. J Invest Dermatol, 2009; 129(3), 629-34.
  • Chang M, Li Y, Yan C, Callis Duffin KP, Matsunami N, Garcia VE, Cargill M, Civello D, Bui N, Catanese JJ, Leppert MF, Krueger GG, Begovich AB, Schrodi SJ. Variants in the 5q31 cytokine gene cluster are associated with psoriasis. Gene Immun, 2008 Mar; 9(2), 176-81.
  • Li Y, Chang M, Schrodi SJ, Callis Duffin K, Matsunami N, Civello D, Bui N, Catanese JJ, Leppert MF, Krueger GG, Begovich AB. The 5q31 variants associated with psoriasis and Crohn's disease are distinct. Hum Mol Genet, 2008; 17(19), 2978-85.
  • Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP, Matsunami N, Ardlie KG, Civello D, Catanese JJ, Leong DU, Panko JM, McAllister LB, Hansen CB, Papenfuss J, Prescott SM, White TJ, Leppert MF, Krueger GG, Begovich AB. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet. 2007 Feb;80(2):273-90.
  • Christensen TE, Callis KP, Papenfuss J, Hoffman MS, Hansen CB, Wong B, Panko JM, Krueger GG. Observations of psoriasis in the absence of therapeutic intervention identifies two unappreciated morphologic variants, thin-plaque and thick-plaque psoriasis, and their associated phenotypes. J Invest Dermatol. 2006 Nov;126(11):2397-403.
  • Herron MD, Hinckley M, Hoffman MS, Papenfuss J, Hansen CB, Callis KP, Krueger GG. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol. 2005 Dec;141(12):1527-34.
  • Krueger GG, Callis K. Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis. Arch Dermatol, 2004; 140(2), 218-25.
  • Krueger GG, Callis KP. Development and use of alefacept to treat psoriasis. J Am Acad Dermatol. 2003 Aug;49(2 Suppl):S87-97. Review.
  • Carlin CS, Callis KP, Krueger GG. Efficacy of acitretin and commercial tanning bed therapy for psoriasis. Arch Dermatol. 2003 Apr;139(4):436-42.